Clinical Trial Update: Phase II Study of HMPL-004 in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase II study of HMPL-004 in ulcerative colitis has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HMPL-004

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-22